Scholarlink

Abstract <p>Substituted tetrahydroquinoline (THQ) derivatives were systematically designed and synthesized via a three-component Povarov reaction, employing <i>N</i>-vinyl carbamate, organocatalyzed substituted anilines, and benzaldehyde derivatives. The resulting THQ derivatives demonstrated a diverse range of functional groups, which potentially broadens their applicability. These compounds were rigorously characterized using various spectroscopic techniques to verify their structures. Subsequent bioevaluation of the synthesized THQs revealed their inhibitory activity against acetylcholinesterase (AChE), highlighting their potential as therapeutic agents for neurodegenerative diseases. All synthesized THQs exhibited IC<sub>50</sub> values ranging from 0.22 to 0.36 μM, which are lower than the IC<sub>50</sub> value of the standard compound tacrine (0.77 μM). The <i>K</i><sub>i</sub> values for the THQs against AChE ranged from 0.370±0.330 to 1.30±0.715 μM. Additionally, molecular docking studies of the THQ-AChE complexes yielded binding scores between –10.8 and –12.4 kcal/mol. The structure-activity relationship (SAR) analysis underscores the significance of THQ structures in medicinal chemistry. These findings suggest that the structural insights gained from this study will be valuable for the future design and synthesis of potent AChE inhibitors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Design, Synthesis, and AChE Inhibition of 4-Amino-tetrahydroquinoline Derivatives: Molecular Docking and Biological Evaluation

  • 期刊论文

  • 发表日期：

    2025年11月1日

查看全文
  • E. Oguz,
  • A. Cetin,
  • M. Z. Kazancioglu,
  • E. A. Kazancioglu,
  • F. Türkan

摘要

Abstract

Substituted tetrahydroquinoline (THQ) derivatives were systematically designed and synthesized via a three-component Povarov reaction, employing N-vinyl carbamate, organocatalyzed substituted anilines, and benzaldehyde derivatives. The resulting THQ derivatives demonstrated a diverse range of functional groups, which potentially broadens their applicability. These compounds were rigorously characterized using various spectroscopic techniques to verify their structures. Subsequent bioevaluation of the synthesized THQs revealed their inhibitory activity against acetylcholinesterase (AChE), highlighting their potential as therapeutic agents for neurodegenerative diseases. All synthesized THQs exhibited IC50 values ranging from 0.22 to 0.36 μM, which are lower than the IC50 value of the standard compound tacrine (0.77 μM). The Ki values for the THQs against AChE ranged from 0.370±0.330 to 1.30±0.715 μM. Additionally, molecular docking studies of the THQ-AChE complexes yielded binding scores between –10.8 and –12.4 kcal/mol. The structure-activity relationship (SAR) analysis underscores the significance of THQ structures in medicinal chemistry. These findings suggest that the structural insights gained from this study will be valuable for the future design and synthesis of potent AChE inhibitors.